The Venture Codex Logo

The Venture Codex

Overview

Evidence-based diagnostic tool for neurodegenerative diseases.

Total Raised

$22 M

Rounds

5

Links

Verticals

Biotechnology
Health Diagnostics
Life Science
Medical

Investment History

  1. Series A

    May 2025

    $14M

  2. Seed

    Apr 2023

    $1M

  3. Seed

    Feb 2022

    $5M

  4. Seed

    Mar 2021

    $2M

Team

Richard Morello

Chief Executive Officer

Todd Dylan Levine

Co-Founder & Chief Medical Officer

Christopher Gibbons

Co-Founder & Senior Scientific Advisor

Matthew Markelon

Regional Sales Executive